Resultados de búsqueda - Cheng, Hailing
- Mostrando 1 - 20 Resultados de 28
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells por Zhang, Lei, Cheng, Hailing, Yue, Yuxia, Li, Shuangzhan, Zhang, Daping, He, Ruili
Publicado 2018Texto -
5
miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway por Cao, Qinxue, Wang, Ning, Ren, Lu, Tian, Jun, Yang, Shaoqin, Cheng, Hailing
Publicado 2020Texto -
6
-
7
-
8
-
9
Melatonin potentiates the cytotoxic effect of Neratinib in HER2(+) breast cancer through promoting endocytosis and lysosomal degradation of HER2 por Liu, Zundong, Sang, Xiaolin, Wang, Min, Liu, Yichao, Liu, Jiao, Wang, Xuefei, Liu, Pixu, Cheng, Hailing
Publicado 2021Texto -
10
-
11
Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling por Usman, Muhammad Waqas, Gao, Jing, Zheng, Tiezheng, Rui, Chunhua, Li, Ting, Bian, Xing, Cheng, Hailing, Liu, Pixu, Luo, Fuwen
Publicado 2018Texto -
12
Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling por Usman, Muhammad Waqas, Gao, Jing, Zheng, Tiezheng, Rui, Chunhua, Li, Ting, Bian, Xing, Cheng, Hailing, Liu, Pixu, Luo, Fuwen
Publicado 2019Texto -
13
PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α por Thorpe, Lauren M., Spangle, Jennifer M., Ohlson, Carolynn E., Cheng, Hailing, Roberts, Thomas M., Cantley, Lewis C., Zhao, Jean J.
Publicado 2017Texto -
14
-
15
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer por Wang, Dong, Wang, Min, Jiang, Nan, Zhang, Yuan, Bian, Xing, Wang, Xiaoqing, Roberts, Thomas M., Zhao, Jean J., Liu, Pixu, Cheng, Hailing
Publicado 2016Texto -
16
A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study por Dai, Zi-Ru, Feng, Lei, Jin, Qiang, Cheng, Hailing, Li, Yan, Ning, Jing, Yu, Yang, Ge, Guang-Bo, Cui, Jing-Nan, Yang, Ling
Publicado 2017Texto -
17
Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes por Wang, Dong, Li, Chengbo, Zhang, Yuan, Wang, Min, Jiang, Nan, Xiang, Lin, Li, Ting, Roberts, Thomas M., Zhao, Jean J., Cheng, Hailing, Liu, Pixu
Publicado 2016Texto -
18
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer por Yi, Jingyan, Liu, Chongya, Tao, Zhiwei, Wang, Min, Jia, Yaxun, Sang, Xiaolin, Shen, Lanlin, Xue, Yijue, Jiang, Kui, Luo, Fuwen, Liu, Pixu, Cheng, Hailing
Publicado 2019Texto -
19
The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis por Utermark, Tamara, Rao, Trisha, Cheng, Hailing, Wang, Qi, Lee, Sang Hyun, Wang, Zhigang C., Iglehart, J. Dirk, Roberts, Thomas M., Muller, William J., Zhao, Jean J.
Publicado 2012Texto -
20
BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C por Zhang, Yuan, Gao, Xiang, Yi, Jingyan, Sang, Xiaolin, Dai, Zhihong, Tao, Zhiwei, Wang, Min, Shen, Lanlin, Jia, Yaxun, Xie, Daqing, Cheng, Hailing, Liu, Zhiyu, Liu, Pixu
Publicado 2021Texto